Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05324566 · ClinicalTrials.gov registry record
Evaluation of ECG Transmission and AI Models Using Apple Watch ECGs and Symptoms Data Collected Using a Mayo iPhone App
A clinical trial of Heart Failure and Health Care Utilization, sponsored by Mayo Clinic.
- Completed
- Registry status
- 4,163
- Enrollment target
- 1
- Study location
NCT05324566: Completed study of Heart Failure and Health Care Utilization, sponsored by Mayo Clinic.
NCT05324566 is a study of Heart Failure and Health Care Utilization that has completed, run by Mayo Clinic. The registered enrollment target is 4,163 participants, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (104% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05324566, a study of Heart Failure and Health Care Utilization, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 4,163 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine if the Electrocardiograms (ECGs) and symptoms data obtained from an Apple Watch and transmitted to Mayo Clinic are of sufficient quality to guide a person's care.
Primary Outcome
Total number of patient-triggered Apple Watch ECGs recorded and uploaded by individual patients over the study period.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,163 participants |
| Start Date | 2021-05-05 |
| Est. Completion | 2024-07-09 |
What the finished NCT05324566 record still lists
NCT05324566 is an observational study that tracks outcomes without assigning an intervention. Its 4,163 participants enrollment target places it among the larger protocols in the corpus, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (104% higher).
The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT05324566 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05324566 about?
NCT05324566 is a clinical study titled "Evaluation of ECG Transmission and AI Models Using Apple Watch ECGs and Symptoms Data Collected Using a Mayo iPhone App". The purpose of the study is to determine if the Electrocardiograms (ECGs) and symptoms data obtained from an Apple Watch and transmitted to Mayo Clinic are of sufficient quality to guide a person's care.
What is the current status of trial NCT05324566?
This trial is currently completed. The enrollment target is 4,163 participants. The study started on 2021-05-05. Estimated completion is 2024-07-09.
What conditions does trial NCT05324566 study?
This clinical trial studies the following conditions: Heart Failure, Health Care Utilization, Arrhythmias, Cardiac.
Who is sponsoring clinical trial NCT05324566?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05324566 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05324566's enrollment target sits among peer trials
4,163 27th of 397 higher than 371 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT07209098 · 4,200 participants
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI